-
No Legwork Mondays – Takeda, Eli Lilly And Actos
Monday, April 21, 2014 - 10:33am | 454Most people have seen advertisements which extol a drug's benefits while simultaneously warning of its potential side effects. Comedians often point out that the side effects can seem worse than conditions the drug addresses. More important, however, the warnings can foreshadow larger...
-
FDA Panel Narrowly Allows Avandia to Remain on the U.S. Market (GSK)
Wednesday, July 14, 2010 - 3:50pm | 178Just moments ago, a Food and Drug Administration (FDA) panel said that clinical data concerning GlaxoSmithKline plc's (NYSE: GSK) diabetes drug, Avandia, is strong enough to raise "significant safety" concerns about the product. Specifically, Dow Jones is reporting that “the current FDA panel voted...